Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore

The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe

Novo Nordisk’s CagriSema delivers strong Phase 3 results across REIMAGINE diabetes trials

Eli Lilly's oral weight-loss drug shows major fat loss across stages of menopause in trials

The results come from post-hoc analyses of more than 1,500 women enrolled in the Phase 3 ATTAIN-1 and ATTAIN-2 trials, presented at the American Diabetes Association’s 86th Scientific Sessions

Barentz opens new pharma hub in Pennsylvania to accelerate growth across North America

New Chesterbrook office strengthens customer engagement, partner collaboration, and regional expansion strategy

Haleon invests Rs. 2000 crore to set up its first manufacturing facility in India

The greenfield facility in Madhya Pradesh expected to create up to 500 direct jobs, in addition to generating indirect employment opportunities

Wanbury FY26 PAT surges 117% to Rs. 66.1 crore

Omnix Medical advances first-in-class antimicrobial OMN6 into Phase II trials

Targeting deadly drug-resistant acinetobacter infections

Virohan launches Rs. 2 crore scholarship to promote health education among women

The initiative opens pathways for female students to pursue healthcare programs across 20+ top universities and colleges in India

Cancer drug “iza-bren” posts strong Phase 3 wins across multiple tumor types

The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials

Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6

First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept